跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Isoglutamine
首页
药物
Isoglutamine
Experimental
Small Molecule
Isoglutamine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
5
H
10
N
2
O
3
CAS 编号
636-65-7
UNII ID
WL74QNU57B
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for synthesizing D-isoglutamine-D-tryptophan
申请人: CHINESE PEPTIDE COMPANY
优先权: 2016
CN
Cell wall acyl-alanyl-D-isoglutamine derivative and its prepn, medicine composition and use
申请人: INST OF MEDICAMENT CHINESE ACA
优先权: 2003
CN
Dietary and pharmaceutical compositions for treatment of anemia, thrombocytopenia, and leukopenia
申请人: PINEGRIN BORIS V
优先权: 2003
US
Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use
申请人: BROVKO FEDOR ALEXANDROVICH
优先权: 2008
US
Phenylacetic acid compositions for treating or preventing hypercholesterolemia
申请人: BURZYNSKI STANISLAW R
优先权: 2000
US
Monoclonal antibody against muramyl peptides
申请人: AGENCY SCIENCE TECH & RES
优先权: 2012
US
2 件公开
Glycopeptides for the treatment of als and other metabolic and autoimmune disorders
申请人: RAJADHYAKSHA V J
优先权: 2004
US
Structural modification method of muramyl dipeptide and application of muramyl dipeptide in delivery of lipid nanoparticles and nucleic acid drugs
申请人: UNIV CHINA PHARMA
优先权: 2023
CN
药物
反馈